334 related articles for article (PubMed ID: 28315877)
1. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.
Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG
Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963
[TBL] [Abstract][Full Text] [Related]
3. The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis.
Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S
Pathol Oncol Res; 2019 Jan; 25(1):311-318. PubMed ID: 29110261
[TBL] [Abstract][Full Text] [Related]
4. The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
Zhang Y; Lun L; Li H; Wang Q; Lin J; Tian R; Pan H; Zhang H; Chen X
Sci Rep; 2017 Oct; 7(1):13080. PubMed ID: 29026116
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of lncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.
Liu J; Lin J; Li Y; Zhang Y; Chen X
Oncotarget; 2017 Jul; 8(30):50051-50060. PubMed ID: 28548946
[TBL] [Abstract][Full Text] [Related]
6. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PANDAR is a Novel Prognostic Biomarker in Patients with Cancer: a Meta-Analysis.
Tian L; Chen X; Lun L; Tian Q; Wang Q; Li H; Song J; Jing X; Zhang Y; Tian R
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775883
[TBL] [Abstract][Full Text] [Related]
8. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
Jiang Y; Le L
Biomed Res Int; 2020; 2020():7974034. PubMed ID: 32802874
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
Li D; Wang R; Wu N; Yu Y
Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lncRNA SOX2OT for Chinese cancer patients: A meta-analysis.
Jing X; Lin J; Wang H; Tian L; Tian R; Zhang Y; Chen X; Zhang J
PLoS One; 2017; 12(5):e0176889. PubMed ID: 28489861
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies.
Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X
Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.
Ren X; He J; Qi L; Li S; Zhang C; Duan Z; Wang W; Tu C; Li Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):353-361. PubMed ID: 31899963
[No Abstract] [Full Text] [Related]
16. AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis.
Chen X; Lin J; Liu Y; Peng J; Cao Y; Su Z; Wang T; Cheng J; Hu D
PLoS One; 2017; 12(2):e0171210. PubMed ID: 28146578
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis.
Dong B; Chen X; Zhang Y; Zhu C; Dong Q
BMC Cancer; 2019 Aug; 19(1):780. PubMed ID: 31391030
[TBL] [Abstract][Full Text] [Related]
18. lncRNA PVT1 in cancer: A review and meta-analysis.
Lu D; Luo P; Wang Q; Ye Y; Wang B
Clin Chim Acta; 2017 Nov; 474():1-7. PubMed ID: 28866116
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
